Back to results
US 12,391,637 B2Granted
Methods to separate cannabinoids from impurities by crystallization
AssigneeNatural Extraction Systems, LLC
InventorsC. Russell Thomas, Douglas G. Metcalf
Life of this patent
Estimating the term…
Abstract
Various aspects of this patent document relate to compositions and methods to purify cannabinoids by crystallization in a water-miscible liquid.
Claims20
A method to produce cannabinoid crystals, comprising:
- (a) providing a precursor composition that comprises (i) a precursor, (ii) contaminant precursors, (iii) original lipids, and (iv) original organic matter, wherein:
- either (i) the precursor is cannabidiolic acid, and the contaminant precursors consist of tetrahydrocannabinolic acid and cannabichromenic acid, or (ii) the precursor is cannabidivarnic acid, and the contaminant precursors consist of tetrahydrocannabivarin acid and cannabichromevarin acid;
- the original lipids consist of one or more of n-nonane;
- n-decane;
- n-undecane;
- n-dodecane;
- n-tridecane;
- n-tetradecane;
- n-pentadecane;
- n-hexadecane;
- n-heptadecane;
- n-octadecane;
- n-nonadecane;
- n-icosane;
- n-heneicosane;
- n-docosane;
- n-tricosane;
- n-tetracosane;
- n-pentacosane;
- n-hexacosane;
- n-heptacosane;
- n-octacosane;
- n-nonacosane;
- n-triacontane;
- n-hentriacontane;
- n-dotriacontane;
- 3,6-dimethyl-tridecane;
- 2,6-dimethyl-tetradecane;
- 2,6-dimethyl-hexadecane;
- 3,6-dimethyl-heptadecane;
- 3,7-dimethyl-heptadecane;
- 3,6-dimethyl-octadecane;
- 3,7-dimethyl-octadecane;
- 3-methyl-heneicosane;
- 3-methyl-tricosane;
- 2-methyl-tetracosane;
- 3-methyl-pentacosane;
- 2-methyl-hexacosane;
- 3-methyl-heptacosane;
- and 3-methyl-triacontane;
- the original organic matter consists of plant-derived molecules and ions that do not vaporize at any temperature of less than 235 degrees Celsius at atmospheric pressure;
- and
- the precursor composition comprises the precursor at a concentration of at least 4 percent by mass;
- (b) heating the precursor composition to produce a decarboxylated composition that comprises (i) a cannabinoid, (ii) contaminants, (iii) lipids, and (iv) organic matter, wherein:
- the heating converts at least 90 percent of the precursor into (i) the cannabinoid and (ii) carbon dioxide by mole of the precursor;
- either (i) the precursor is cannabidiolic acid, and the cannabinoid is cannabidiol, or (ii) the precursor is cannabidivarnic acid, and the cannabinoid is cannabidivarin;
- the heating converts at least 90 percent of the contaminant precursors into (i) the contaminants and (ii) carbon dioxide by mole of the contaminant precursors;
- either (i) the contaminant precursors consist of tetrahydrocannabinolic acid and cannabichromenic acid, and the contaminants consist of tetrahydrocannabinol and cannabichromene, or (ii) the contaminant precursors consist of tetrahydrocannabivarin acid and cannabichromevarin acid, and the contaminants consist of tetrahydrocannabivarin and cannabichromevarin;
- the lipids consist of a portion of the original lipids that survive the heating;
- and
- the organic matter consists of a portion of the original organic matter that survives the heating;
- (c) combining a portion of the decarboxylated composition with ethanol to produce a dewaxing composition that comprises (i) ethanol, (ii) a portion of the cannabinoid of the decarboxylated composition, (iii) a portion of the contaminants of the decarboxylated composition, (iv) a portion of the lipids of the decarboxylated composition, and (v) a portion of the organic matter of the decarboxylated composition, wherein:
- the portion of the cannabinoid of the decarboxylated composition comprises the cannabinoid at a concentration of at least 30 percent and no greater than 80 percent by mass;
- the portion of the cannabinoid of the decarboxylated composition comprises the cannabinoid and the contaminants at a ratio of at least 3:1 and no greater than 80:1 by mass;
- the portion of the cannabinoid of the decarboxylated composition comprises the cannabinoid and the lipids at a concentration of at least 1:2 and no greater than 40:1 by mass;
- the portion of the cannabinoid of the decarboxylated composition comprises the cannabinoid and the organic matter at a concentration of at least 1:2 and no greater than 40:1 by mass;
- and
- the dewaxing composition comprises the ethanol at a concentration of at least 20 percent and no greater than 90 percent by mass;
- (d) cooling a portion of the dewaxing composition to produce a mixture that comprises (i) a portion of the ethanol of the dewaxing composition, (ii) a portion of the cannabinoid of the dewaxing composition, (iii) a portion of the contaminants of the dewaxing composition, (iv) a portion of the lipids of the dewaxing composition, and (v) a portion of the organic matter of the dewaxing composition, wherein:
- the mixture comprises a solid phase and a liquid phase;
- the cooling converts at least 65 percent of the portion of the lipids of the dewaxing composition into solid-phase lipids by mass such that the solid phase of the mixture comprises at least 65 percent of the lipids of the mixture by mass;
- the liquid phase comprises at least 90 percent of the ethanol of the mixture by mass;
- the liquid phase comprises at least 90 percent of the cannabinoid of the mixture by mass;
- the liquid phase comprises at least 90 percent of the contaminants of the mixture by mass;
- and
- the liquid phase comprises at least a portion of the organic matter of the mixture;
- (e) separating a portion of the liquid phase from the solid phase to produce a dewaxed composition that comprises (i) a portion of the ethanol of the liquid phase, (ii) a portion of the cannabinoid of the liquid phase, (iii) a portion of the contaminants of the liquid phase, and (iv) a portion of the organic matter of the liquid phase;
- (f) separating ethanol from a portion of the dewaxed composition to produce a concentrate composition that comprises (i) a portion of the cannabinoid of the dewaxed composition, (ii) a portion of the contaminants of the dewaxed composition, and (iii) a portion of the organic matter of the dewaxed composition, wherein:
- the separating is performed by vaporizing the ethanol from the portion of the dewaxed composition;
- and
- the concentrate composition lacks ethanol at a concentration greater than 20 percent by mass;
- (g) heating a portion of the concentrate composition to produce a vapor phase and residual organic matter, wherein:
- the portion of the concentrate composition comprises the cannabinoid and the contaminants at a combined concentration of at least 40 percent and no greater than 85 percent by mass;
- the vapor phase comprises (i) a portion of the cannabinoid of the concentrate composition and (ii) a portion of the contaminants of the concentrate composition;
- the residual organic matter comprises a portion of the organic matter of the concentrate composition;
- and
- the residual organic matter consists of one or both of a solid and a liquid;
- (h) separating a portion of the vapor phase from the residual organic matter to produce a distillate that comprises (i) a portion of the cannabinoid of the vapor phase, and (ii) a portion of the contaminants of the vapor phase;
- (i) condensing a portion of the distillate into a condensed phase that comprises (i) a portion of the cannabinoid of the distillate, and (ii) a portion of the contaminants of the distillate, wherein:
- the condensed phase comprises the cannabinoid at a concentration of at least 70 percent and no greater than 90 percent by mass;
- and
- the condensed phase comprises the contaminants at a concentration of at least 1 percent and no greater than 20 percent by mass;
- (j) combining a portion of the condensed composition and ethanol to produce a crystallization composition that comprises (i) ethanol, (ii) a portion of the cannabinoid of the condensed phase, and (iii) a portion of the contaminants of the condensed phase;
- (k) incubating a portion of the crystallization composition at a crystallization temperature to produce crystals and residual liquid, wherein:
- the cannabinoid has both a concentration and a solubility in the portion of the crystallization composition, and the crystallization temperature is a temperature at which the concentration is greater than the solubility;
- the crystals comprise a portion of the cannabinoid of the crystallization composition;
- and
- the residual liquid comprises a portion of the ethanol of the crystallization composition and a portion of the contaminants of the crystallization composition;
- and
- (l) separating a portion of the crystals from the residual liquid to produce a product, wherein:
- the product comprises the cannabinoid at a concentration of at least 90 percent by mass;
- the product lacks the contaminants at a concentration of greater than 0.3 percent by mass;
- the product lacks the lipids at a concentration of greater than 1 percent by mass;
- the product lacks the organic matter at a concentration greater than 1 percent by mass;
- the crystals are a solid;
- the crystals have a melting point;
- and
- the crystals lack a glass-transition temperature.
95 more elements
A composition, comprising a cannabinoid, an impurity, a liquid phase, and a solid phase, wherein:
- the cannabinoid has the molecular formula CxHyO2;
- the impurity has the molecular formula CxHzO2;
- “x” is at least 17 and no greater than 24;
- “y” is at least 22 and no greater than 36;
- “z” is at least 22 and no greater than 34;
- the cannabinoid and the impurity each comprise an alkyl;
- the alkyl of the cannabinoid is identical to the alkyl of the impurity;
- the alkyl is either methyl, propyl, pentyl, or heptyl;
- the cannabinoid is either (i) 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-alkylbenzene-1,3-diol, and “z” equals “y” minus either 0, 2, or 4, or (ii) 2-[(2E)-3,7-dimethylocta-2,6-diene-1-yl]-5-alkylbenzene-1,3-diol, and “z” equals “y” minus either 2, 4, or 6;
- the impurity comprises a 2H-chromene ring that either (i) comprises exactly 4 substituents that consist of a 2-methyl substituent;
- a 2-(4-methylpent-3-en-1-yl) substituent;
- a 5-hydroxy substituent;
- and a 7-alkyl substituent that is the alkyl of the impurity, wherein “z” equals “y” minus either 0 or 2 or (ii) is the 2H-chromene of a 6H-benzo[c]chromene ring that comprises exactly 5 substituents that consist of a 1-hydroxy substituent;
- a 3-alkyl substituent that is the alkyl of the impurity;
- two 6-methyl substituents;
- and a 9-methyl substituent, wherein “z” equals “y” minus either 0, 2, 4, or 6;
- the composition comprises the cannabinoid and the impurity at a ratio of at least 3:1 and no greater than 333:1 by mass;
- the liquid phase consists of one or more liquids;
- the liquid phase has an average density of at least 770 and no greater than 1260 grams per liter;
- the liquid phase comprises greater than 50 percent of the impurity of the composition by mass;
- the liquid phase is in both physical and chemical communication with the solid phase such that the physical and chemical properties of the composition control the extent to which the cannabinoid partitions between the liquid phase and the solid phase;
- the solid phase consists of one or more solids;
- the solid phase comprises greater than 50 percent of the cannabinoid of the composition by mass;
- the solid phase comprises a crystal phase that consists of one or more crystals;
- the crystal phase comprises at least 90 percent of the cannabinoid of the solid phase by mass;
- the crystal phase comprises the cannabinoid at a concentration of at least 90 percent by mass;
- the composition comprises the liquid phase and the crystal phase at a ratio of at least 1:10 and no greater than 20:1 by mass;
- and
- the composition lacks molecules that comprise at least 5 carbon atoms and no greater than 16 carbon atoms at a concentration greater than 20 percent by mass.
26 more elements
A composition, comprising a cannabinoid, an impurity, a liquid phase, and a solid phase, wherein:
- either the cannabinoid is cannabidiol and the impurity is tetrahydrocannabinol or the cannabinoid is cannabidivarin and the impurity is tetrahydrocannabivarin;
- the composition comprises the cannabinoid and the impurity at a ratio of at least 3:1 and no greater than 333:1 by mass;
- the liquid phase consists of one or more liquids;
- the liquid phase has an average density of at least 770 and no greater than 1260 grams per liter;
- the liquid phase comprises greater than 50 percent of the impurity of the composition by mass;
- the solid phase consists of one or more solids;
- the solid phase comprises greater than 50 percent of the cannabinoid of the composition by mass;
- the solid phase comprises a crystal phase that consists of one or more crystals;
- the crystal phase comprises at least 90 percent of the cannabinoid of the solid phase by mass;
- the crystal phase comprises the cannabinoid at a concentration of at least 90 percent by mass;
- the composition comprises the liquid phase and the crystal phase at a ratio of at least 1:10 and no greater than 20:1 by mass;
- and
- the composition lacks molecules that comprise at least 5 carbon atoms and no greater than 16 carbon atoms at a concentration greater than 20 percent by mass.
10 more elements
Dependencies are inferred from the claim text.